Tax News Update    Email this document    Print this document  

May 21, 2024
2024-1029

House Energy and Commerce Subcommittee advances 21 health care bills

the House Energy and Commerce Health Subcommittee advanced 21 bills to extend Medicare beneficiaries' access to telehealth services for two years, paid for by pharmacy benefit manager (PBM) reforms and Medicare clinical laboratory payment cuts; increase access to remote monitoring services; encourage innovation in pediatric rare disease cancer treatments, and more.

Although the initial version of the Telehealth Modernization Act (H.R. 7623) sought to permanently extend COVID-19 telehealth flexibilities under Medicare, which expire this year, a substitute amendment scaled it back to two years, aligning with the two-year telehealth extension bill approved by the Ways and Means Committee last week. Both bills also include a five-year extension of waivers for the Acute Hospital Care at Home program.

The committee did not vote on two rare disease drug bills that had been scheduled for votes: Retaining Access and Restoring Exclusivity (RARE) Act (H.R. 7383) and Creating Hope Reauthorization Act of 2024 (H.R. 7384). Click here for the full list of bills and amendments.

More information is available here.

Additional information is also available in the attached WCEY Alert.

* * * * * * * * * *
Attachment

House subcommittee advances 21 health care bills

* * * * * * * * * *
Contact Information

For additional information concerning this Alert, please contact:

Washington Council Ernst & Young

 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 1996 – 2024, Ernst & Young LLP

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

EY US Tax News Update Master Agreement | EY Privacy Statement